B, B., & S, P. (2024). Letter: Comparing first-line infliximab and vedolizumab for ulcerative colitis-it depends on how you use the drug. Authors' reply. Alimentary pharmacology & therapeutics, 59(1), 142. https://doi.org/10.1111/apt.17796
Chicago Style (17th ed.) CitationB, Bokemeyer, and Plachta-Danielzik S. "Letter: Comparing First-line Infliximab and Vedolizumab for Ulcerative Colitis-it Depends on How You Use the Drug. Authors' Reply." Alimentary Pharmacology & Therapeutics 59, no. 1 (2024): 142. https://doi.org/10.1111/apt.17796.
MLA (9th ed.) CitationB, Bokemeyer, and Plachta-Danielzik S. "Letter: Comparing First-line Infliximab and Vedolizumab for Ulcerative Colitis-it Depends on How You Use the Drug. Authors' Reply." Alimentary Pharmacology & Therapeutics, vol. 59, no. 1, 2024, p. 142, https://doi.org/10.1111/apt.17796.